May 09, 2022 / 08:30PM GMT
Operator
Good day, and thank you for standing by. Welcome to the Praxis Precision Medicines First Quarter 2022 Corporate Update, Question and Answer Conference Call. (Operator Instructions)
And now, it is my pleasure to hand the conference over to your first speaker today, Alex Kane, Vice President, Investor Relations and Corporate Communications at Praxis. Thank you. Please go ahead.
Alex Kane - Praxis Precision Medicines, Inc. - VP of IR & Corporate Communications
Thank you, Paul. Good afternoon, everyone, and thank you for joining us today for our first quarter 2022 corporate update Q&A call. With me on the call is our President and Chief Executive Officer, Marcio Souza; our Chief Medical Officer, Bernard Ravina; and our CFO, Tim Kelly. Following the press releases and video update issued this afternoon, we will focus today's call on your questions.
We ask that you keep to one question initially, and then please feel free to rejoin the queue for follow-up questions as needed.
Before we proceed, I would like to remind you that
Q1 2022 Praxis Precision Medicines Inc Earnings Call Transcript
May 10, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers